November 8, 2018
BioLineRx Reports Significant Progress Across Oncology Programs and Provides Third Quarter Financial Update
November 1, 2018
BioLineRx to Report Third Quarter 2018 Results on November 8, 2018
October 20, 2018
BioLineRx Discloses Additional Data from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress
October 19, 2018
BioLineRx Presents Top-line Results from Phase 2a COMBAT/KEYNOTE-202 Study in Pancreatic Cancer at ESMO 2018 Congress